APA

Prymula R., Chlibek R., Splino M., Kaliskova E., Kohl I., Lommel P. & Schuerman L. (20081007). Safety of the 11-valent pneumococcal vaccine conjugated to non-typeable Haemophilus influenzae-derived protein D in the first 2 years of life and immunogenicity of the co-administered hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated polio virus, Haemophilus influenzae type b and control hepatitis A vaccines. : Vaccine.

Chicago

Prymula Roman, Chlibek Roman, Splino Miroslav, Kaliskova Eva, Kohl Igor, Lommel Patricia and Schuerman Lode. 20081007. Safety of the 11-valent pneumococcal vaccine conjugated to non-typeable Haemophilus influenzae-derived protein D in the first 2 years of life and immunogenicity of the co-administered hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated polio virus, Haemophilus influenzae type b and control hepatitis A vaccines. : Vaccine.

Harvard

Prymula R., Chlibek R., Splino M., Kaliskova E., Kohl I., Lommel P. and Schuerman L. (20081007). Safety of the 11-valent pneumococcal vaccine conjugated to non-typeable Haemophilus influenzae-derived protein D in the first 2 years of life and immunogenicity of the co-administered hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated polio virus, Haemophilus influenzae type b and control hepatitis A vaccines. : Vaccine.

MLA

Prymula Roman, Chlibek Roman, Splino Miroslav, Kaliskova Eva, Kohl Igor, Lommel Patricia and Schuerman Lode. Safety of the 11-valent pneumococcal vaccine conjugated to non-typeable Haemophilus influenzae-derived protein D in the first 2 years of life and immunogenicity of the co-administered hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated polio virus, Haemophilus influenzae type b and control hepatitis A vaccines. : Vaccine. 20081007.